BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31693255)

  • 1. Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer.
    Liu WJ; Zhao G; Zhang CY; Yang CQ; Zeng XB; Li J; Zhu K; Zhao SQ; Lu HM; Yin DC; Lin SX
    J Cell Biochem; 2020 Apr; 121(4):2756-2769. PubMed ID: 31693255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner.
    Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI
    Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells.
    Benbrahim-Tallaa L; Liu J; Webber MM; Waalkes MP
    Prostate; 2007 Feb; 67(2):135-45. PubMed ID: 17075824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen signalling and steroid receptor crosstalk in endocrine cancers.
    Claessens F; Tilley W
    Endocr Relat Cancer; 2014 Aug; 21(4):E3-5. PubMed ID: 25052914
    [No Abstract]   [Full Text] [Related]  

  • 5. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Androgen and Estrogen Ablation and Inhibition of Steroid Biosynthetic Enzyme Treatment for Castration-resistant Prostate Cancer.
    Sinha AA; Pomroy FE; Wilson MJ
    Anticancer Res; 2016 Aug; 36(8):3847-54. PubMed ID: 27466486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen Receptor Signaling Pathways Involved in Invasion and Colony Formation of Androgen-Independent Prostate Cancer Cells PC-3.
    Lombardi APG; Cavalheiro RP; Porto CS; Vicente CM
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer.
    Salvi S; Bonafè M; Bravaccini S
    Semin Cancer Biol; 2020 Feb; 60():132-137. PubMed ID: 31002873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dual effects of androgens on mammary gland].
    Brettes JP; Mathelin C
    Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal breast cancer, androgens, and aromatase inhibitors.
    Campagnoli C; Pasanisi P; Castellano I; Abbà C; Brucato T; Berrino F
    Breast Cancer Res Treat; 2013 May; 139(1):1-11. PubMed ID: 23572296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A perspective on the role of estrogen in hormone-induced prostate carcinogenesis.
    Bosland MC
    Cancer Lett; 2013 Jun; 334(1):28-33. PubMed ID: 22939996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.
    Fleyshman D; Cheney P; Ströse A; Mudambi S; Safina A; Commane M; Purmal A; Morgan K; Wang NJ; Gray J; Spellman PT; Issaeva N; Gurova K
    Cell Cycle; 2016; 15(3):455-70. PubMed ID: 26694952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
    Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
    Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
    De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
    BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal Steroids and Resistance to Hormonal Blockade of Prostate and Breast Cancer.
    Michael P; Roversi G; Brown K; Sharifi N
    Endocrinology; 2023 Jan; 164(3):. PubMed ID: 36580423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer stem cells: the role of androgen and estrogen receptors.
    Di Zazzo E; Galasso G; Giovannelli P; Di Donato M; Di Santi A; Cernera G; Rossi V; Abbondanza C; Moncharmont B; Sinisi AA; Castoria G; Migliaccio A
    Oncotarget; 2016 Jan; 7(1):193-208. PubMed ID: 26506594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.
    Kollara A; Diamandis EP; Brown TJ
    J Steroid Biochem Mol Biol; 2003 Apr; 84(5):493-502. PubMed ID: 12767274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
    Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
    Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.